Compositions and methods for inhibiting xdh expression
US-2026055414-A1 · Feb 26, 2026 · US
Novo Nordisk As was listed as an assignee on 2 patent publications in 2026.
| Metric | Value |
|---|---|
| Company | Novo Nordisk As |
| Year | 2026 |
| Patents | 2 |
Representative publications for Novo Nordisk As in 2026.
US-2026055414-A1 · Feb 26, 2026 · US
US-2026049309-A1 · Feb 19, 2026 · US
Most common classification codes for Novo Nordisk As in 2026.
| CPC | Patents |
|---|---|
| A61K31/712 | 2 |
| C12N15/1137 | 2 |
| C12N2310/14 | 2 |
| C12N2310/315 | 2 |
| C12N2310/321 | 2 |
Navigate to parent entity pages.